3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
39
Leukemia
16
Congenital Abnormalities
10
Leukemia, Monocytic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Myelodysplastic Syndromes
5
Recurrence
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Eosinophilic, Acute
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Promyelocytic, Acute
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Basophilic, Acute
2
Neoplasms
1
Myeloproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Childhood Acute Promyelocytic Leukemia With PML-RARA
1
Interventions
Tacrolimus
29
fludarabine phosphate
21
Methotrexate
21
Cyclophosphamide
21
Mycophenolic Acid
18
Busulfan
15
Antilymphocyte Serum
14
Whole-Body Irradiation
13
Sirolimus
12
fludarabine
11
Peripheral Blood Stem Cell Transplantation
11
Cyclosporine
9
thymoglobulin
8
Melphalan
8
Hematopoietic Stem Cell Transplantation
6
Granulocyte Colony-Stimulating Factor
6
Filgrastim
6
Rituximab
5
Pentostatin
5
Methylprednisolone
5
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Cyclosporins
4
ruxolitinib
3
Vorinostat
3
Transplantation
3
Flow Cytometry
3
Etoposide
3
merphos
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Graft vs Host Disease
×
Idarubicin
×
Clear all
No trials found.